Table 1. Characteristics of the study population and several subpopulations.
All females:n(%) | Group Ia: n(%) | Group IIb: n(%) | Group IIIc: n(%) | |
---|---|---|---|---|
Race | ||||
″African American | 297 (75·0) | 209 (74·4) | 80 (83·3) | 75 (77·3) |
″Other | 99 (25·0) | 72 (25·6) | 16 (16·7) | 22 (22·7) |
Age at enrolment | ||||
″< 17 years | 144 (36·4) | 108 (38·4) | 44 (45·8) | 47 (48·5)e* |
″≥ 17 years | 252 (63·6) | 173 (61·6) | 52 (54·2) | 50 (51·5) |
Sexual partners | ||||
″< 2 | 297 (75·0) | 210 (74·7) | 70 (72·9) | 63 (64·9)e* |
″≥ 2 | 99 (25·0) | 71 (25·3) | 26 (27·1) | 34 (35·1) |
HIV-1 infection | ||||
″Seropositive | 254 (64·1) | 195 (69·4) | 60 (62·5) | 58 (59·8) |
″Seronegative | 142 (35·9) | 86 (30·6) | 36 (37·5) | 39 (40·2) |
Oral contraceptive in past 3 monthsd | ||||
″No | 219 (51·6) | 160 (57·8) | 51 (54·3) | 56 (59·0) |
″Yes | 168 (43·4) | 117 (42·2) | 43 (45·7) | 39 (41·1) |
Genital wartsd | ||||
″No | 292 (80·2) | 204 (78·2) | 77 (89·5) | 73 (84·9) |
″Yes | 72 (19·8) | 57 (21·8) | 9 (10·5) | 13 (15·1) |
Prior chlamydial infectiond | ||||
″No | 232 (63·7) | 157 (60·1) | 49 (57·0) | 47 (54·6) |
″Yes | 132 (36·3) | 104 (39·9) | 37 (43·0) | 39 (45·4) |
Gonorrhoead | ||||
″No | 281 (77·2) | 194 (74·3) | 61 (70·9) | 65 (75·6) |
″Yes | 83 (22·8) | 67 (25·7) | 25 (29·1) | 21 (24·4) |
Bacterial vaginosisd | ||||
″No | 277 (76·1) | 196 (75·1) | 65 (75·6) | 68 (79·1) |
″Yes | 87 (23·9) | 65 (24·9) | 21 (24·4) | 18 (20·9) |
CD4+ T cells count (cells/µl)d | ||||
″< 400 | 83 (21·5) | 58 (21·1) | 10 (10·8)e* | 9 (9·5)e** |
″≥ 400 | 304 (78·6) | 217 (78·9) | 83 (89·2) | 86 (90·5) |
Subjects with at least four visits of endocervical cytokine data available (Group I).
Subjects who acquired Chlamydia trachomatis within two consecutive visits (C. trachomatis negative visit followed immediately by C. trachomatis positive visit).
Subjects cleared C. trachomatis infection within two consecutive visits (C. trachomatis positive visit followed immediately by C. trachomatis negative visit).
Few subjects had missing information.
P < 0·05 (*) or P < 0·01 (**) compared with all subjects.